← All trials
NCT00386542
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2006
- Primary completion
- Nov 1, 2009
- Completion date
- May 1, 2010
- First posted
- —
- Last posted
- —
- Enrollment
- 450
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Centers for Disease Control and Prevention (CDC)Lead sponsor
- World Health OrganizationStudy chair
- World Health OrganizationCollaborator
- Pan American Health OrganizationCollaborator
- Sanofi-AventisCollaborator
- Hospital Infantil Dr. Robert Reid CabralCollaborator
- Bioject Medical Technologies, Inc.Collaborator
- Centers for Disease Control and Prevention (CDC)Overall official - principal investigator
- Centers for Disease Control and Prevention (CDC)Study director
- PATHCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.